<?xml version="1.0" encoding="UTF-8"?>
<p>Rao et al. reportyed DNA-intercalating naphthalimide-benzothiazole derivatives and evaluated their cytotoxicities against three different cancer cell lines such as HT29, A549 and MCF-7. Among all tested derivatives, the naphthalimide derivative 
 <bold>66</bold> (
 <xref ref-type="fig" rid="F0040">Figure 40</xref>) possessed good antitumor activity against HT-29, A549 and MCF-7 cell lines having IC
 <sub>50</sub> values of 3.72 ± 0.3 µM, 4.074 ± 0.3 µM and 07.91 ± 0.4 µM respectively. The naphthalimide 
 <bold>67</bold> (
 <xref ref-type="fig" rid="F0040">Figure 40</xref>) showed antitumor activity with IC
 <sub>50</sub> values of 03.47 ± 0.2 µM for HT-29, 03.89 ± 0.3 µM for A549 and 05.08 ± 0.3 µM for MCF-7 cell lines
 <xref rid="CIT0064" ref-type="bibr">
  <sup>64</sup>
 </xref>.
</p>
